KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Organon (OGN) Revenue (2020 - 2026)

Organon has reported Revenue over the past 7 years, most recently at $1.5 billion for Q1 2026.

  • For Q1 2026, Revenue fell 3.5% year-over-year to $1.5 billion; the TTM value through Mar 2026 reached $6.2 billion, down 2.08%, while the annual FY2025 figure was $6.2 billion, 2.92% down from the prior year.
  • Revenue for Q1 2026 was $1.5 billion at Organon, down from $1.5 billion in the prior quarter.
  • Over five years, Revenue peaked at $1.6 billion in Q1 2024 and troughed at $1.5 billion in Q1 2026.
  • A 5-year average of $1.6 billion and a median of $1.6 billion in 2024 define the central range for Revenue.
  • Biggest five-year swings in Revenue: decreased 7.36% in 2022 and later increased 7.61% in 2023.
  • Year by year, Revenue stood at $1.5 billion in 2022, then grew by 7.61% to $1.6 billion in 2023, then decreased by 0.38% to $1.6 billion in 2024, then dropped by 5.34% to $1.5 billion in 2025, then dropped by 3.12% to $1.5 billion in 2026.
  • Business Quant data shows Revenue for OGN at $1.5 billion in Q1 2026, $1.5 billion in Q4 2025, and $1.6 billion in Q3 2025.